Literature DB >> 8256247

Histologically atypical Pneumocystis carinii pneumonia.

N M Foley1, M H Griffiths, R F Miller.   

Abstract

BACKGROUND: Infection with Pneumocystis carinii typically results in a pneumonia which histologically is seen to consist of an eosinophilic foamy alveolar exudate associated with a mild plasma cell interstitial infiltrate. Special stains show that cysts of P carinii lie within the alveolar exudate. Atypical histological appearances may occasionally be seen, including a granulomatous pneumonia and diffuse alveolar damage. In these patients the clinical presentation may be atypical and results of investigations negative unless lung biopsies are performed and tissue obtained for histological examination.
METHODS: The incidence and mode of presentation of histologically atypical pneumocystis pneumonia was studied in a cohort of HIV-I antibody positive patients.
RESULTS: Over a 30 month period 138 patients had pneumocystis pneumonia, of whom eight (6%) had atypical histological appearances which were diagnosed (after negative bronchoalveolar lavage) by open lung biopsy in five, percutaneous biopsy in one, and at post mortem examination in two. Atypical appearances included granulomatous inflammation in four patients, "pneumocystoma" in two (one also had extrapulmonary pneumocystosis), bronchiolitis obliterans organising pneumonia in one patient, diffuse alveolar damage and subpleural cysts in one (who also had intrapulmonary cytomegalovirus infection), and extrapulmonary pneumocystosis in two patients.
CONCLUSIONS: Various atypical histological appearances may be seen in pneumocystis pneumonia. Lung biopsy (either percutaneous or open) should be considered when bronchoalveolar lavage is repeatedly negative and evidence of P carinii should be sought, by use of special stains, in all lung biopsy material from HIV-I antibody positive patients.

Entities:  

Mesh:

Year:  1993        PMID: 8256247      PMCID: PMC464808          DOI: 10.1136/thx.48.10.996

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  23 in total

1.  Granulomatous Pneumocystis carinii pneumonia in a patient with the acquired immunodeficiency syndrome.

Authors:  H D Birley; J R Buscombe; M H Griffiths; S J Semple; R F Miller
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

2.  Cavitating and noncavitating granulomas in AIDS patients with Pneumocystis pneumonitis.

Authors:  J S Klein; M Warnock; W R Webb; G Gamsu
Journal:  AJR Am J Roentgenol       Date:  1989-04       Impact factor: 3.959

Review 3.  Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas.

Authors:  W D Travis; S Pittaluga; G Y Lipschik; F P Ognibene; A F Suffredini; H Masur; I Feuerstein; J Kovacs; H I Pass; K S Condron
Journal:  Am J Surg Pathol       Date:  1990-07       Impact factor: 6.394

4.  Pneumocystis carinii pneumonia: spectrum of parenchymal CT findings.

Authors:  J E Kuhlman; M Kavuru; E K Fishman; S S Siegelman
Journal:  Radiology       Date:  1990-06       Impact factor: 11.105

5.  Pulmonary cysts associated with Pneumocystis carinii pneumonia in patients with AIDS.

Authors:  J S Sandhu; P C Goodman
Journal:  Radiology       Date:  1989-10       Impact factor: 11.105

6.  Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.

Authors:  W Blumenfeld; N Basgoz; W F Owen; D M Schmidt
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

7.  High resolution computed tomography of Pneumocystis carinii pneumonia in AIDS.

Authors:  E Moskovic; R Miller; M Pearson
Journal:  Clin Radiol       Date:  1990-10       Impact factor: 2.350

8.  Diagnosis of pulmonary disease in human immunodeficiency virus infection: role of transbronchial biopsy and bronchoalveolar lavage.

Authors:  M H Griffiths; G Kocjan; R F Miller; P Godfrey-Faussett
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

9.  Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation.

Authors:  I M Feurestein; A Archer; J M Pluda; P S Francis; J Falloon; H Masur; H I Pass; W D Travis
Journal:  Radiology       Date:  1990-03       Impact factor: 11.105

10.  Disseminated pneumocystis carinii infection in AIDS.

Authors:  R J Coker; D Clark; E L Claydon; M Gompels; J G Ainsworth; S B Lucas; R Miller; R D Goldin; A J Pinching; J R Harris
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

View more
  6 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

3.  Granulomatous Pneumocystis carinii pneumonia: DNA amplification studies on bronchoscopic alveolar lavage samples.

Authors:  A E Wakefield; R F Miller; L A Guiver; J M Hopkin
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

4.  Interstitial pneumonitis in patients infected with the human immunodeficiency virus.

Authors:  M H Griffiths; R F Miller; S J Semple
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

5.  Open lung biopsy for investigation of acute respiratory episodes in patients with HIV infection and AIDS.

Authors:  R F Miller; W B Pugsley; M H Griffiths
Journal:  Genitourin Med       Date:  1995-10

6.  Exoantigens of Paracoccidioides spp. Promote Proliferation and Modulation of Human and Mouse Pulmonary Fibroblasts.

Authors:  Débora de Fátima Almeida Donanzam; Tatiani Ayako Goto Donato; Karoline Haghata Dos Reis; Adriely Primo da Silva; Angela Carolina Finato; Amanda Ribeiro Dos Santos; Ricardo Souza Cavalcante; Rinaldo Poncio Mendes; James Venturini
Journal:  Front Cell Infect Microbiol       Date:  2020-10-30       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.